Abstract
Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.
| Original language | English |
|---|---|
| Article number | 2420 |
| Pages (from-to) | 654A-654A |
| Number of pages | 1 |
| Journal | Blood |
| Volume | 102 |
| Issue number | 11 |
| Publication status | Published - 16 Nov 2003 |
| Event | 45th Annual Meeting of the American-Society-of-Hematology - San Diego, United States Duration: 6 Dec 2003 → 9 Dec 2003 |
Keywords
- pre-treatment
- bryostatin
- lonafirnib
- efficacy
- imatinib
- G0/G1
- ph+ cell line
Fingerprint
Dive into the research topics of 'Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver